Biochemical analysis of metallo-β-lactamase NDM-3 from a multidrug-resistant escherichia coli strain isolated in japan

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 6, 2014, Pages 3538-3540

  Tada, Tatsuya ^a   Miyoshi Akiyama, Tohru ^a   Shimada, Kayo ^a   Kirikae, Teruo ^a  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; AZTREONAM; CEFEPIME; CEFOSELIS; CEFOTAXIME; CEFOXITIN; CEFPIROME; CEFRADINE; CEFTAZIDIME; CEFTRIAXONE; DORIPENEM; IMIPENEM; LATAMOXEF; MEROPENEM; METALLO BETA LACTAMASE; NEW DELHI METALLO BETA LACTAMASE 1; NEW DELHI METALLO BETA LACTAMASE 3; PENICILLIN G; SULTAMICILLIN; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; BETA LACTAM; BETA LACTAMASE; BETA-LACTAMASE NDM-1; CARBAPENEM DERIVATIVE;

ARTICLE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CHEMICAL ANALYSIS; ENZYME ACTIVITY; ESCHERICHIA COLI; EXPRESSION VECTOR; FECES; GENETIC ANALYSIS; HUMAN; JAPAN; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PLASMID; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SOUTHERN BLOTTING; DRUG EFFECTS; ENZYMOLOGY; ESCHERICHIA COLI INFECTION; GENETICS; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MULTIDRUG RESISTANCE;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; BETA-LACTAMS; CARBAPENEMS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS; JAPAN; MICROBIAL SENSITIVITY TESTS; PLASMIDS;

EID: 84901258143     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02793-13     Document Type: Article

References (30)

1. Queenan AM, Bush K. 2007. Carbapenemases: the versatile betalactamases. Clin. Microbiol. Rev. 20:440-458. http://dx.doi.org/10.1128/CMR.00001-07.
2. Schlesinger SR, Kim SG, Lee JS, Kim SK. 2011. Purification development and characterization of the zinc-dependent metallo-beta-lactamase from Bacillus anthracis. Biotechnol. Lett. 33:1417-1422. http://dx.doi.org/10.1007/s10529-011- 0569-9.
3. Bush K. 2001. New beta-lactamases in Gram-negative bacteria: diversity and impact on the selection of antimicrobial therapy. Clin. Infect. Dis. 32:1085-1089. http://dx.doi.org/10.1086/319610.
4. Yong D, Toleman MA, Giske CG, Cho HS, Sundman K, Lee K, Walsh TR. 2009. Characterization of a new metallo-beta-lactamase gene, blaNDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob. Agents Chemother. 53:5046-5054. http://dx.doi.org/10.1128/AAC.00774-09.
5. Cornaglia G, Giamarellou H, Rossolini GM. 2011. Metallo-betalactamases: a last frontier for beta-lactams? Lancet Infect. Dis. 11:381-393. http://dx.doi.org/10.1016/S1473-3099(11)70056-1.
6. Pillai DR, McGeer A, Low DE. 2011. New Delhi metallo-betalactamase-1 in Enterobacteriaceae: emerging resistance. CMAJ 183:59-64. http://dx.doi.org/10. 1503/cmaj.101487.
7. Kaase M, Nordmann P, Wichelhaus TA, Gatermann SG, Bonnin RA, Poirel L. 2011. NDM-2 carbapenemase in Acinetobacter baumannii from Egypt. J. Antimicrob. Chemother. 66:1260-1262. http://dx.doi.org/10.1093/jac/dkr135.
8. Espinal P, Fugazza G, Lopez Y, Kasma M, Lerman Y, Malhotra-Kumar S, Goossens H, Carmeli Y, Vila J. 2011. Dissemination of an NDM-2-producing Acinetobacter baumannii clone in an Israeli rehabilitation center. Antimicrob. Agents Chemother. 55:5396-5398. http://dx.doi.org/10.1128/AAC.00679-11.
9. Poirel L, Bonnin RA, Boulanger A, Schrenzel J, Kaase M, Nordmann P. 2012. Tn125-related acquisition of blaNDM-like genes in Acinetobacter baumannii. Antimicrob. Agents Chemother. 56:1087-1089. http://dx.doi.org/10.1128/AAC.05620- 11.
10. Ghazawi A, Sonnevend A, Bonnin RA, Poirel L, Nordmann P, Hashmey R, Rizvi TA, Hamadeh MB, Pal T. 2012. NDM-2 carbapenemaseproducing Acinetobacter baumannii in the United Arab Emirates. Clin. Microbiol. Infect. 18:E34-E36. http://dx.doi.org/10.1111/j.1469-0691.2011.03726.x.
11. Rogers BA, Sidjabat HE, Silvey A, Anderson TL, Perera S, Li J, Paterson DL. 2013. Treatment options for New Delhi metallo-beta-lactamaseharboring Enterobacteriaceae. Microb. Drug Resist. 19:100-103. http://dx.doi.org/10.1089/ mdr.2012.0063.
12. Nordmann P, Boulanger AE, Poirel L. 2012. NDM-4 metallo-betalactamase with increased carbapenemase activity from Escherichia coli. Antimicrob. Agents Chemother. 56:2184-2186. http://dx.doi.org/10.1128/AAC.05961-11.
13. Hornsey M, Phee L, Wareham DW. 2011. A novel variant, NDM-5, of the New Delhi metallo-beta-lactamase in a multidrug-resistant Escherichia coli ST648 isolate recovered from a patient in the United Kingdom. Antimicrob. Agents Chemother. 55:5952-5954. http://dx.doi.org/10.1128/AAC.05108-11.
14. Williamson DA, Sidjabat HE, Freeman JT, Roberts SA, Silvey A, Woodhouse R, Mowat E, Dyet K, Paterson DL, Blackmore T, Burns A, Heffernan H. 2012. Identification and molecular characterisation of New Delhi metallo-beta- lactamase-1 (NDM-1)-And NDM-6-producing Enterobacteriaceae from New Zealand hospitals. Int. J. Antimicrob. Agents 39:529-533. http://dx.doi.org/10.1016/j. ijantimicag.2012.02.017.
15. Cuzon G, Bonnin RA, Nordmann P. 2013. First identification of novel NDM carbapenemase, NDM-7, in Escherichia coli in France. PLoS One. 8:e61322. http://dx.doi.org/10.1371/journal.pone.0061322.
16. Gottig S, Hamprecht AG, Christ S, Kempf VA, Wichelhaus TA. 2013. Detection of NDM-7 in Germany, a new variant of the New Delhi metallobeta-lactamase with increased carbapenemase activity. J. Antimicrob. Chemother. 68:1737-1740. http://dx.doi.org/10.1093/jac/dkt088.
17. Tada T, Miyoshi-Akiyama T, Dahal RK, Sah MK, Ohara H, Kirikae T, Pokhrel BM. 2013. NDM-8 metallo-beta-lactamase in a multidrugresistant Escherichia coli strain isolated in Nepal. Antimicrob. Agents Chemother. 57:2394-2396. http://dx.doi.org/10.1128/AAC.02553-12.
18. Suzuki MT, Taylor LT, DeLong EF. 2000. Quantitative analysis of smallsubunit rRNA genes in mixed microbial populations via 5=-nuclease assays. Appl. Environ. Microbiol. 66:4605-4614. http://dx.doi.org/10.1128/AEM.66.11. 4605-4614.2000.
19. Clinical and Laboratory Standards Institute. 2012. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 9th ed. Approved standard M07-A9. Clinical and Laboratory Standards Institute, Wayne, PA.
20. Ellington MJ, Kistler J, Livermore DM, Woodford N. 2007. Multiplex PCR for rapid detection of genes encoding acquired metallo-betalactamases. J. Antimicrob. Chemother. 59:321-322. http://dx.doi.org/10.1093/jac/dkl481.
21. Poirel L, Walsh TR, Cuvillier V, Nordmann P. 2011. Multiplex PCR for detection of acquired carbapenemase genes. Diagn. Microbiol. Infect. Dis. 70:119-123. http://dx.doi.org/10.1016/j.diagmicrobio.2010.12.002.
22. Boschi L, Mercuri PS, Riccio ML, Amicosante G, Galleni M, Frere JM, Rossolini GM. 2000. The Legionella (Fluoribacter) gormanii metallo- betalactamase: a new member of the highly divergent lineage of molecularsubclass B3 beta-lactamases. Antimicrob. Agents Chemother. 44:1538-1543. http://dx.doi.org/10.1128/AAC.44.6.1538-1543.2000.
23. Crowder MW, Walsh TR, Banovic L, Pettit M, Spencer J. 1998. Overexpression, purification, and characterization of the cloned metallo-betalactamase L1 from Stenotrophomonas maltophilia. Antimicrob. Agents Chemother. 42:921-926.
24. Queenan AM, Shang W, Flamm R, Bush K. 2010. Hydrolysis and inhibition profiles of beta-lactamases from molecular classes A to D with doripenem, imipenem, and meropenem. Antimicrob. Agents Chemother. 54:565-569. http://dx.doi.org/10.1128/AAC.01004-09.
25. Tarczynski MC, Meyer WJ, Min JJ, Wood KA, Hellwig RJ. 1994. Two-minute miniprep method for plasmid DNA isolation. Biotechniques 16:514-519.
26. Bonnin RA, Poirel L, Carattoli A, Nordmann P. 2012. Characterization of an IncFII plasmid encoding NDM-1 from Escherichia coli ST131. PLoS One 7:e34752. http://dx.doi.org/10.1371/journal.pone.0034752.
27. Green VL, Verma A, Owens RJ, Phillips SE, Carr SB. 2011. Structure of New Delhi metallo-beta-lactamase 1 (NDM-1). Acta Crystallogr. F Struct. Biol. Cryst. Commun. 67:1160-1164. http://dx.doi.org/10.1107/S1744309111029654.
28. Kim Y, Tesar C, Mire J, Jedrzejczak R, Binkowski A, Babnigg G, Sacchettini J, Joachimiak A. 2011. Structure of apo-And monometalated forms of NDM-1-A highly potent carbapenem-hydrolyzing metallobeta-lactamase. PLoS One 6:e24621. http://dx.doi.org/10.1371/journal.pone.0024621.
29. King D, Strynadka N. 2011. Crystal structure of New Delhi metallo-betalactamase reveals molecular basis for antibiotic resistance. Protein Sci. 20:1484-1491. http://dx.doi.org/10.1002/pro.697.
30. Zhang H, Hao Q. 2011. Crystal structure of NDM-1 reveals a common beta-lactam hydrolysis mechanism. FASEB J. 25:2574-2582. http://dx.doi.org/10. 1096/fj.11-184036.